After more than ten years of research, Director Liu Guanjun discovered that scorpion venom contains more than a dozen active peptides, which are particularly effective in treating cardiovascular and cerebrovascular diseases and intractable pain that harm humans.
After further research, it was found that the peptides in scorpion venom that have therapeutic effects on cardiovascular and cerebrovascular diseases include thrombolytic peptides, cardiovascular polytubular peptides and nerve growth peptides. Thrombolytic peptides can not only dissolve new thrombi but also old thrombi; vascular peptides can remove vegetations and attachments on blood vessel walls, unblock narrow blood vessels, and restore the normal blood supply function of blood vessels; nerve growth peptides can repair and regenerate Damaged cranial nerves and brain cells, allowing the brain to restore brain function.
Director Liu Guanjun uses ultrafiltration, membrane filtration, ion exchange chromatography and reversed-phase chromatography to remove impurities and toxic substances in scorpion venom, retaining only the active peptides in the scorpion venom and making injections. It has been initially used clinically and has amazing effects on cardiovascular diseases. However, the transportation and storage requirements are extremely high, making it difficult to promote and apply on a large scale.
Director Liu Guanjun cooperated with the theory of traditional Chinese medicine and based on the active peptides of scorpion venom, combined with traditional Chinese medicine Polygonum multiflorum, wolfberry, yam, etc. and used wine as the solvent to make an oral liquid dosage form, which can not only maintain the activity of scorpion venom , the oil price clears the therapeutic effect. After three phases of clinical verification, it showed remarkable efficacy and no toxic side effects. In 2002, it was approved by the State Food and Drug Administration as the only new oral drug for scorpion venom - Biao Feng No. 1. After the advent of Bafeng No. 1, it has cured tens of thousands of cardiovascular patients. It was awarded the "Science and Technology Progress Award" by the national science and technology department, and the drug was recognized as a "high-tech product." In 2008, it was presented at the academic conference of the International Cardiovascular and Cerebrovascular Rehabilitation Association. , recommended as a “Chinese patent medicine for cardiovascular and cerebrovascular rehabilitation”.
Director Liu Guanjun has extracted anti-cancer peptides, new blood vessel peptides, nerve growth peptides, and liver-protecting peptides from scorpion venom into capsules, and has overcome technical difficulties and made them into capsules. The Beno miracle drug developed for coronary heart disease is about to be launched, and is expected to benefit more patients with difficult diseases.